Shaji Kumar, MD, and Prashant Kapoor, MD: Update on CAR T-Cell Therapies for Multiple Myeloma

Posted: Wednesday, September 2, 2020

Shaji Kumar, MD, and Prashant Kapoor, MD, both of the Mayo Clinic, discuss results from three abstracts on B-cell maturation antigen–targeted CAR T-cell therapies for relapsed and refractory multiple myeloma: the KarMMa study on idecabtagene vicleucel; an update of the phase I/II EVOLVE trial of orvacabtagene autoleucel; and CARTITUDE-1, a phase Ib/II study of JNJ-4528.